Repligen Corporation Board of Directors

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Mr. Olivier Loeillot

Mr. Olivier Loeillot

President, CEO & Director

Mr. Neil Whitfield

Mr. Neil Whitfield

VP & Global Head of Sales

Mr. Keith Lee Robinson

Mr. Keith Lee Robinson

Chief Information Officer

Mr. James R. Bylund

Mr. James R. Bylund

Chief Operating Officer

Mr. Ralf Kuriyel

Mr. Ralf Kuriyel

Senior Vice President of Research & Development

Mr. Jason K. Garland

Mr. Jason K. Garland

CFO & Chief Compliance Officer

Ms. Sondra S. Newman

Ms. Sondra S. Newman

Global Head of Investor Relations

Ms. Teresa Ferragamo

Ms. Teresa Ferragamo

Senior Director of Marketing

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.